Last reviewed · How we verify

NCT06573021

Fluorescent Cholangiography in Acute Cholecystitis

Completed Last updated 27 August 2024
What this trial tests

trial testing Near-infrared fluorescent cholangiography in Acute Cholecystitis in 81 participants. Completed in 31 May 2024.

Timeline
1 January 2023
Primary endpoint
31 May 2024
31 May 2024

Quick facts

Lead sponsorUniversity Hospital of Ferrara
StatusCompleted
Study typeOBSERVATIONAL
Enrollment81
Start date1 January 2023
Primary completion31 May 2024
Estimated completion31 May 2024
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital of Ferrara

Who can join

18 and older, any sex, with Acute Cholecystitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Currently, there is limited scientific evidence regarding the effectiveness of fluorescent cholangiography in emergency cholecystectomy for acute cholecystitis. The primary aim of this study was to assess the efficacy of near-infrared fluorescent cholangiography to detect extrahepatic biliary anatomy in different severity degrees of acute cholecystitis.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The role of fluorescent cholangiography to improve operative safety in different severity degrees of acute cholecystitis during emergency laparoscopic cholecystectomy: a prospective cohort study.
    Pesce A, Pesce A, Fabbri N, Bonazza L, et al · · 2024 · cited 11× · PMID 39806739 · DOI 10.1097/js9.0000000000002160

Verify or expand the search:

Other recruiting trials for Acute Cholecystitis

Currently open trials in the same condition.

Other University Hospital of Ferrara trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06573021.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing